Company Summary: Seer, Inc.

Business Overview

Seer, Inc. is a biotechnology company focused on proteomics, specifically providing tools and services for detailed protein analysis. The company aims to enable researchers and healthcare providers to better understand biological processes and improve diagnostics and therapeutics.

Key Details

• Number of Instruments Shipped in 2024: 10, bringing the total to 72 instruments shipped since inception.
• Research and Publications: Increased peer-reviewed publications, preprints, and reviews to 32 in 2024, up from 8 in 2023.
• Partnerships: Entered into a co-marketing and sales agreement with Thermo Fisher Scientific, expanding access to deep, unbiased proteomics at scale.
• Customer Base: While specific number of customers is not provided, the focus is on research institutions and laboratories utilizing proteomics technology.

Financial Information (2024)

• Revenue (GAAP): Approximately $14.2 million for the full year 2024.
• Net Income (Loss): The company experienced a net loss of approximately $86.6 million in 2024.
• Stockholders and Market Data:
  • The market value of the company’s common equity held by non-affiliates was approximately $95.8 million as of June 28, 2024.
  • Shares Outstanding (as of February 26, 2025):
    • 55,737,066 shares of Class A common stock
    • 4,044,969 shares of Class B common stock

Employees

• The document indicates a company size of 50 to 500 employees (based on peer group parameters). Exact employee count is not specified, but the size suggests a mid-stage biotech company.

Corporation Status

• Incorporation: Delaware
• Stock Trading Symbol: SEER on Nasdaq Global Select Market.

Summary

Seer, Inc. develops advanced proteomics tools to facilitate protein analysis for biomedical research, with a focus on expanding their instrument deployment, publications, and strategic partnerships. The company reported revenue of $14.2 million in 2024 and experienced a net loss of approximately $86.6 million. It has shipped 72 instruments to date and operates with a workforce estimated within the mid-sized range.